Refractory Respiratory Failure

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Refractory Respiratory Failure trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2

NCT04943224

Optimization of the Time and Dosage of Trametinib in BRAF Negative Juvenile Patients

Prospective, interventional, open, randomized, single-center, non-commercial clinical trial to optimize treatment and dosage of trametinib in juvenile patients…

Poland12 participantsStarted 2021-04-01

Treatment: Trametinib

All recent trials (16 shown)

Active — Not RecruitingNot Applicable

NCT06114992

Servo-n HFOV Study: Safety and Performance in Neonates and Infants

The purpose of this study is to evaluate the safety and performance of High-Frequency Oscillatory Ventilation (HFOV) modes of the Servo-n ventilator in neonates…

France, Poland, Switzerland75 participantsStarted 2024-07-15

Treatment: Servo-n HFOV modes

CompletedNot Applicable

NCT03098589

Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)

To understand the safety and efficacy of Revlimid® Capsules 2.5 mg and 5 mg (hereinafter referred to as Revlimid) under actual conditions of use in patients wit…

Japan1,149 participantsStarted 2017-05-30

Treatment: Revlimid

Refractory Respiratory Failure

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Optimization of the Time and Dosage of Trametinib in BRAF Negative Juvenile Patients

All recent trials (16 shown)

Servo-n HFOV Study: Safety and Performance in Neonates and Infants

Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Optimization of the Time and Dosage of Trametinib in BRAF Negative Juvenile Patients

All recent trials (16 shown)

Servo-n HFOV Study: Safety and Performance in Neonates and Infants

Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)

Intravenous Continuous LMWH Seems to be Safe Alternative to UFH in VV ECMO Patients

Tunneled Pleural Catheters for Refractory Effusions Attributed to Congestive Heart Failure (TREAT-CHF) Trial

ECMO for Critically Ill Patients With Respiratory Failure and/or Circulatory Failure

A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have…

Effect of Arterio-venous ECMO on Severe Sepsis and ARDS

Leg Exercise During ECMO

Extracorporeal Membrane Oxygenation (ECMO) and Coronavirus Disease (COVID) 19

AMR PH GL 2007 CL001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line Chemotherapy

T790M Mutation on ctDNA in Patients With NSCLC After EGFR-TKI Failure

Saudi Outcomes of ECMO-treated MERS-CoV Patients

Efficacy Study of SIMVASTATIN to Treat Chronic Rhinosinusitis After Failure of Optimal Treatment

Airway Management Study in Physician Manned Helicopter Emergency Medical Services

Trial of a Breathlessness Intervention Service for Intractable Breathlessness